US WorldMeds

embryonic stem cells
Favicon Fierce Biotech

Cell therapy biotech keeps adapting, selling 4 programs for $55M

USWM plans on offering jobs to about half of Adaptimmune’s workforce. As of Dec. 31, 2024, the biotech had 506 employees.
Gabrielle Masson Jul 28, 2025 10:52am
photo of a green light on a stoplight

US WorldMeds scores FDA approval in aggressive cancer

Dec 14, 2023 4:06pm